spectrometer operating at a normal frequency of 400 MHz using the specified deuterated solvent. All spectra have been calibrated to the residual deuterated solvent peak and chemical shifts reported in ppm.
All fluorine NMR experiments are externally referenced to trichlorofluoromethane. Spectra were analysed and processed using Topspin 3.2 software. Multiplicities in the NMR are described as: br s = broad singlet, d = doublet, dd = doublet of doublets, t = triplet, td = triplet of doublets, q = quartet, m = multiplet, br = broad, app = apparent; coupling constants are reported in Hz. Melting points were recorded using capillary tubes on a Mel-Temp TM electro thermal melting point apparatus. Infrared spectra were recorded from neat samples using a Perkin-Elmer Spectrum BX FT-IR spectrometer and analysed using Spectrum v5.3.1
software. RP-HPLC were obtained using a Agilent 1200 apparatus with a Eclipse XDB-C18 column (5 M, 4.6 x 15 mm) running a gradient of 1 mL/min over 20 minutes. 
Chromatography
Thin layer chromatography was performed using Merck aluminium plates coated with 0.2 mm silica gel-60 F 254 . After elution TLC plates were visualised under UV light. Flash column chromatography was performed using silica gel (particle size 60 M) unless otherwise specified all samples were dry loaded onto silica prior to separation. Chromatography was performed using a Biotage Isolera ACI TM with wave monitoring set to 214 nm and 254 nm.
Reagents and Glassware
All chemicals used were purchased from Sigma-Aldrich or Thermo-Fisher Scientific. All glassware was oven dried prior to use. Anhydrous solvents were commercially purchased and assumed to conform to manufacturers specifications. All water for reagents, reactions and assays was purified using a Merk Millipore Milli-Q direct water purification system.
Biological Procedures
E. coli gyrase supercoiling and cleavage assay kits were purchased from Inspiralis. Gyrase was prepared from overexpressing strains JMtacA and JMtacB and supplied as an A 2 B 2 complex in dilution buffer.
Dilution buffer consisted of 50 mM Tris.HCl (pH 7.5), 100 nM KCl, 2 mM DTT, 1 mM EDTA and 50% (w/v) glycerol. Supercoiling assay buffer (SAB) consisted of 35 mM Tris.HCl (pH 7.5), 24 mM KCl, 4 mM MgCl 2 , 2 mM DTT, 1.8 mM spermidine, 1 mM ATP. The same dilution buffer was utilised for cleavage stabilisation assays. Cleavage assay buffer consisted (CAB) of 35 mM Tris.HCl (pH 7.5), 24 mM KCL, 4 mM MgCl 2 , 2 mM DTT, 1.8 mM spermidine, 6.5% (w/v) glycerol, 0.1 mg/mL albumin. All enzymes were stored at -80C.
Supercoiled or relaxed pBR322 DNA was supplied with the assay kits. TAE buffer was used for electrophoresis containing 40 mM Tris acetate and 1 mM EDTA.
Agarose gel electrophoresis
1% (w/v) agarose was added to TAE buffer and brought to the boil until the agarose had completely dissolved. The gel was allowed to cool for 5 minutes prior to being cast into a rack with a comb. The gel was allowed to solidify for 45 minutes and the comb removed; the gel was placed into an electrophoresis tank and covered with TAE buffer. Experimental samples were then loaded into the wells.
Supercoiling assay
The inhibitory effect of compounds on gyrase supercoiling activity was assessed using the Inspiralis assay kits and following the manufacturers instructions. Compounds were weighed into an eppendorf tube and dissolved in DMSO. Serial dilutions were performed using water. For each compound a master mix (MM) was prepared using 0.5 L of relaxed pBR322 DNA, 6 L of DB, 6 L of SAB and 15. 
Cleavage stabilisation assay
Compounds were weighed into an eppendorf and dissolved in DMSO. Serial dilutions were carried out using water. For each compound a master mix (MM) was prepared using 0.3 L of supercoiled pBR322
DNA, 6 L of DB, 6 L of CAB and 15.7 L of water. Diluted samples and MM were prepared whilst on ice prior to incubation to minimise intrinsic supercoiling activity. A 28 L aliquot of MM was used for the positive control and the volume made up to 30 L with water. Subsequently 1 L of enzyme was added
for every compound to be tested including the negative control, the MM was homogenised. Afterwards 29 L of MM was dispensed into an eppendorf tube, with 1 L of compound added to each eppendorf tube.
Samples were centrifuged at 13,200 RPM for 5 seconds prior to incubation. Samples were incubated at 37C for 30 minutes. After which, 0.3 L of 20% SDS and 0.5 L of proteinase K was added to each sample, a further incubation was performed for an additional 30 minutes. To arrest the reaction, a mixture of 30 L iso-amyl alcohol and chloroform (1:24) and 15 L of 40% (w/v) sucrose, 0.1 M Tris.HCl (pH 8.0), 0.1 M EDTA, 0.5 mg/mL bromophenol blue (STEB buffer) was added. The sample was centrifuged at 13,200 RPM for 5 minutes, and a 15 L aliquot of aqueous layer loaded onto a 1% agarose gel. The topoisomers and supercoiled DNA were separated by electrophoresis. The gel was stained in mixture of TAE and ethidium bromide (1 g/mL) for 15 minutes before being distained using TAE buffer for 15 minutes. The gel was then visualised under UV light.
Experimental procedures and characterisation N-(2-Oxo-2H-chromen-3-yl) acetamide (6)
Salicylaldehyde ( 
3-Amino-2H-chromen-2-one (7)
Compound 6 (1.99 g, 9.08 mmol) was added to a mixture of conc. HCl and EtOH (2:1) and refluxed for 5
h. Subsequently, the solution was allowed to cool to room temperature. The pH was adjusted with NaOH to pH 7 and the precipitate filtered and desiccated to provide a yellow powder as the desired product (866 mg, 54% 2, 157.5, 149.6, 129.5, 127.8, 124.9, 124.5, 123.6, 119.6, 115.8, 35.9, 33.7, 28.7, 28.6, 28.54, 28.53, 25.0 24.5 purity.
1-Cyclopropyl-6-fluoro-4-oxo-7-(4-{9-[(2-oxo-2H-chromen-3-yl)carbamoyl]nonanoyl}piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate (11)
EDC (56.72 mg, 0.29 mmol) was added to a solution of compound 8 (94 mg, 0.27mmol) in 30% pyridine/ DCM (10 mL) and stirred vigorously for 5 minutes to allow activation of the carboxylic acid. Subsequently, compound 10 (96 mg, 0.27 mmol) was added and the reaction stirred for 23 h. After which it was acidified with 1 M HCl, extracted three times with EtOAc and the organic layer dried over MgSO 4 . The solvent was removed under reduced pressure and the resultant product triturated with diethyl ether and DCM. The product was purified by flash column chromatography using a gradient from 50% EtOAc/hexanes to 100%
EtOAc. The product was obtained as a white solid (81.50 mg, 44% 45.7, 41.4, 37.8, 34.6, 33.3, 29.5, 29.31 29.28, 29.19, 25.40, 25.37, 14.6, 8.3. 19 showed 97% purity.
1-Cyclopropyl-6-fluoro-4-oxo-7-(4-{9-[2-oxo-2H-chromen-3-yl)carbamoyl]nonanoyl}piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid (4)
Compound 11 2, 37.8, 35.4, 33.3, 29.5, 29.30, 29.28, 29.19, 25.4, 25.3, 8.4 The organic layers were pooled together, dried over MgSO 4 and the solvent removed to give the title product as a white solid (1.13 g, 83% 174.5, 171.7, 138.2, 129.0, 124.2, 119.9, 51.6, 37.8, 34.2, 29.25, 29.20, 29.12, 25.7, 25.0 174.7, 139.9, 129.8, 125.1, 121.3, 38.0, 35.0, 30.28, 30.26, 30.17, 26.9, 26 45.6, 41.3, 37.6, 34.7, 33.3, 29.3, 29.3, 29.1, 25.6, 25.3, 14.5, 8.2. 19 Relaxed pBR322 plasmid DNA is used as a negative control (-), and incubated in the presence of gyrase as a positive control (+). SD8 is used as a comparator at a concentration of 1 M. NC indicates nicked circle DNA; R, relaxed DNA; SC, supercoiled DNA.
